Study Finds Cancer Cells Use a New Fuel in Absence of Sugar
In mice, researchers find the metabolite uridine can feed pancreatic cancer cells when glucose availability is low.
In mice, researchers find the metabolite uridine can feed pancreatic cancer cells when glucose availability is low.
James Baker, MD and team are launching a new program to identify specific genetic variants that predispose people to AD and food allergies.
Preeti Malani, MD, along with the National Poll on Healthy Aging, released new findings of trends in loneliness and isolation among older adults 50-80 years old, between 2018-2023.
Congratulations to J. Michelle Kahlenberg, MD, PhD who was selected as the Department of Internal Medicine Vice Chair for Basic and Translational Research, effective June 1, 2023.
As the Federal COVID-19 Public Health Emergency Declaration comes to an end, here are 11 things to be aware of with the help of MCIDT affiliate Dr. Preeti Malani.
Gary Hammer, MD, PhD, and team share their latest updates in Adrenal cancer.
Lona Mody, MD, and other palliative care team members help dispel some common myths around their profession.
Ray Zuo, MD, and Jason Knight, MD, PhD, discover a class of functional autoantibodies in antiphospholipid syndrome patients that contributes to the disease's development.
Sofia Merajver, MD, PhD, and team use microfluidic devices to track what happens to cancer cells as they migrate and take root in the brain.
Ray Zuo, MD, and team suggest antiphospholipid antibodies may be present in seemingly healthy people, increasing their risk of a heart attack or stroke over time.
Anna Lok, MD, and team examine data from an NIH-funded study to determine if there's any racial disparity in hepatitis B treatment initiation in North America.
Robert Fontana, MD, and team examine measuring blood levels of a short-lived protein to help predict which patients would survive without the help of a transplant.
Megan R. Haymart, MD, and team assess the current state of thyroid cancer care through exploration of possible over diagnosis to new therapies and health equity concerns.
Robert Fontana, MD examines data around a 2011 FDA drug mandate.
Eugene Chen, MD, PhD, discusses the development of an amino acid compound successfully treating nonalcoholic fatty liver disease in non-human primates; brings hope for first human treatment.
Robert Fontana, MD, finds that measuring blood levels of a short-lived protein helps predict which patients would survive without the help of a transplant.
Rodica Pop-Busui, MD, PhD, discusses how the price cap will affect diabetes patients.
Allison Schulman, MD MPH, discusses several non-invasive therapies for treating obesity.
Robert Fontana, MD, examines data around a 2011 FDA drug mandate.